Causeway Capital Management’s Pfizer PFE Stock Holding History

Causeway Capital Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$46.2M	Buy	1,916,801 +2,582	+0.1%	+$67.5K	0.5%	40
2026 Q1	$53.8M	Sell	1,914,219 -177,500	-8%	-$4.73M	0.66%	34
2025 Q4	$52.1M	Buy	2,091,719 +19,672	+0.9%	+$496K	0.72%	35
2025 Q3	$52.8M	Buy	2,072,047 +108,735	+6%	+$2.68M	0.7%	33
2025 Q2	$47.6M	Sell	1,963,312 -60,943	-3%	-$1.42M	0.75%	27
2025 Q1	$51.3M	Buy	2,024,255 +191,465	+10%	+$5.01M	1.07%	23
2024 Q4	$48.6M	Sell	1,832,790 -378,520	-17%	-$10.3M	1.11%	26
2024 Q3	$64M	Buy	2,211,310 +207,651	+10%	+$6.06M	1.57%	20
2024 Q2	$56.1M	Buy	+2,003,659	New	+$55.2M	1.53%	21

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Causeway Capital Management's PFE Position: Q2 2026 in Review

Causeway Capital Management increased its Pfizer (PFE) stake by 0.13% in Q2 2026, buying an estimated $67.5K and bringing the position to 1,916,801 shares worth $46.2M. The position accounts for 0.5% of the portfolio, ranked #40.

Causeway Capital Management first reported a position in PFE in Q2 2024 and has held it in 9 quarters since. The position peaked at $64M in Q3 2024. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Causeway Capital Management held 1,916,801 shares of Pfizer worth $46.2M as of Q2 2026.
Causeway Capital Management bought 2,582 Pfizer shares in Q2 2026, an estimated $67.5K.
Pfizer made up 0.5% of Causeway Capital Management's portfolio in Q2 2026, its #40 holding.
Causeway Capital Management first reported a position in Pfizer in Q2 2024 and has held it in 9 quarters since.
Causeway Capital Management's Pfizer position peaked at $64M in Q3 2024.
2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Causeway Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.